An immune-protein score combining TRAIL, IP-10 and CRP for predicting severe COVID-19 disease

Cytokine. 2023 Sep:169:156246. doi: 10.1016/j.cyto.2023.156246. Epub 2023 Jun 2.

Abstract

COVID-19 patients are oftentimes over- or under-treated due to a deficit in predictive management tools. This study reports derivation of an algorithm that integrates the host levels of TRAIL, IP-10, and CRP into a single numeric score that is an early indicator of severe outcome for COVID-19 patients and can identify patients at-risk to deteriorate. 394 COVID-19 patients were eligible; 29% meeting a severe outcome (intensive care unit admission/non-invasive or invasive ventilation/death). The score's area under the receiver operating characteristic curve (AUC) was 0.86, superior to IL-6 (AUC 0.77; p = 0.033) and CRP (AUC 0.78; p < 0.001). Likelihood of severe outcome increased significantly (p < 0.001) with higher scores. The score differentiated severe patients who further deteriorated from those who improved (p = 0.004) and projected 14-day survival probabilities (p < 0.001). The score accurately predicted COVID-19 patients at-risk for severe outcome, and therefore has potential to facilitate timely care escalation and de-escalation and appropriate resource allocation.

Keywords: COVID-19 disease severity prediction; Emergency Department; Host-immune protein score; SARS-CoV-2.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19*
  • Chemokine CXCL10
  • Humans
  • Intensive Care Units
  • Prognosis
  • ROC Curve
  • Retrospective Studies

Substances

  • Chemokine CXCL10